The 4 mg/mL injection strength may be used for intralesional and soft tissue administration. Doses range from mg to 4 mg injected as a single dose at the appropriate site. For soft tissue and bursal injections a dose of 2 to 4 mg is recommended. Ganglia require a dose of 1 to 2 mg. A dose of to 1 mg is used for injection into tendon sheaths. Usually employed when condition to be treated is limited to 1 or 2 sites. Dosage dependent upon degree of inflammation, size, disease state, and location of affected area. Repeat doses may be given from once every 3 to 5 days to once every 2 to 3 weeks.
In the pre-marketing controlled clinical studies and their open extensions (2,423 patients with median duration of follow-up of approximately 18 months), % of patients were discontinued due to adverse reactions. The most common adverse reactions that led to treatment discontinuation were: gastrointestinal disorders (%), myalgia (%), and arthralgia (%). The most commonly reported adverse reactions (incidence ≥5%) in Simvastatin controlled clinical trials were: upper respiratory infections (%), headache (%), abdominal pain (%), constipation (%), and nausea (%).
Tren E is exclusively for the building up of muscle mass and increasing strength. It is a steroid that is oil based and mainly used for veterinarian purposes but is made illegally as well. Body builders use it in order to minimise the number of injections they need to have. It does have very strong properties of androgens and can produce excessive sweating, nightmares, insomnia and a noticeable decrease in cardiovascular capability. Anyone who does sport or anything physical should not take Tren E. When you take Tren E you need to increase your fluid intake to make up for the excessive sweating. Other side effects include: